Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Atrial fibrillation (AF) is the most common cardiac rhythm disorder in clinical practice. In the last two decades the number of hospitalizations for AF has increased two- to three-fold. More than 6 million people worldwide suffer from atrial fibrillation (AF), a cardiac disorder that results in systemic emboli. Patients with AF are 5 times more likely to have a stroke compared with those without AF.
This registry will collection information on two devices that are used to treat AF. The WATCHMAN and LARIAT. The differences in techniques and subsequent effects of the two devices on outcomes related to AF has not been studied. This study will look to compare the two devices to see how the outcomes may vary.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| WATCHMAN | Patients that had the WATCHMAN device implanted |
| |
| LARIAT LAA Device | patients that had LARIAT LAA device implanted |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| LARIAT LAA | Device | The LARIAT snare device is an over-the-wire device guided over the LAA to enable ligation of the LAA. The LARIAT can be opened and closed as desired for ideal positioning without risk of suture deployment. |
| Measure | Description | Time Frame |
|---|---|---|
| Effect of LAA occlusion by LARIAT device | This registry will provide data on patient outcomes at different times during follow up. This includes: changes in the appendage size, shape and patients medical history. | Change from Day 0 to Day 90 |
| Effect of LAA occlusion by LARIAT device | This registry will provide data on patient outcomes at different times during follow up.This includes: changes in the appendage size, shape and patients medical history. | Change from Day 0 to 356 post-procedure |
| Measure | Description | Time Frame |
|---|---|---|
| Compare effectiveness of LAA occlusion procedure by evaluating LAA jet velocities | Days 0, 90, 180, 365 post-procedure and annually thereafter |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients who have had a LARIAT LAA device occlusion.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dhanunjaya Lakkireddy, MD | University of Kansas Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | United States |
Not provided
| ID | Term |
|---|---|
| D001281 | Atrial Fibrillation |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
| WATCHMAN | Device | The WATCHMAN is an expandable device deployed in the LAA via a trans-septal catheter. The implanted device has a self-expanding nitinol frame to secure it in the LAA. The fabric of the WATCHMAN device is permeable to blood. |
|
| D013568 |
| Pathological Conditions, Signs and Symptoms |